Mezzion Pharma Co. Ltd. | |
Stock Exchange | Korea Exchange |
EPS |
KRW2623 |
Market Cap |
KRW712.72 B |
Shares Outstanding |
8.62 M |
Public Float |
6.07 M |
Address |
3th Floor, C&H Building Seoul SL 06167 Korea, Republic Of |
Employees | - |
Website | http://www.mezzion.co.kr |
Updated | 09/14/2018 |
Mezzion Pharma Co., Ltd. engages in the development, production, and licensing of pharmaceutical products. Its products include erectile dysfunction, benign prostatic hyperplasia, and fontan therapeutic drugs. The company was founded by Park Dong-Hyun on September 25, 2002 and is headquartered in Seoul, South Korea. |